(Q57013058)

1

0 references

M Biffi

2

0 references

A Capucci

3

0 references

G Bronzetti

4

0 references

G M Ayers

5

0 references

R Zannoli

6

0 references

A Branzi

7

0 references

B Magnani

8

0 references

Mauro Biffi

2

0 references

Alessandro Capucci

3

0 references

Gabriele Bronzetti

4

0 references

Gregory M Ayers

5

0 references

Romano Zannoli

6

0 references

Angelo Branzi

7

0 references

Bruno Magnani

Journal of the American College of Cardiology

8

0 references

language of work or name

English

0 references

publication date

February 1999

0 references

published in

0 references

volume

33

0 references

issue

2

0 references

page(s)

333-41

0 references

333-341

0 references

cites work

Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Internal cardioversion of atrial fibrillation in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

The use of quinidine in cardioversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Direct current shock and antidysrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Effects of flecainide on the atrial defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Electrical cardioversion after amiodarone administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Atrial fibrillation: maintenance of sinus rhythm versus rate control

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Development of fluoroimmunoassays for flecainide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Efficacy of flecainide for the reversion of acute onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

1 reference

7 January 2021

Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Effects of encainide and its metabolites on energy requirements for defibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Effects of flecainide on defibrillation thresholds in the anesthetized dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Effects of acute and prolonged administration of propafenone on internal defibrillation in the pig

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Antiarrhythmic drugs in patients with an automatic implantable defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

The Interaction of Antiarrhythmic Drugs and the Energy for Cardioversion of Chronic Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Electrophysiologic mechanisms of perpetuation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Mode of Action of a New Class IC Drug (ORG 7797) Against Atrial Fibrillation in Conscious Doges

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery*

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

An implantable atrial defibrillator. An impossible dream?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Efficacy and Tolerability in Fully Conscious Patients of Transvenous Low-Energy Internal Atrial Cardioversion for Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Proarrhythmia in patients treated for atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

The pattern of onset and spontaneous cessation of atrial fibrillation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021

Changes in intracardiac atrial cardioversion threshold at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900577-4

7 January 2021